Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $31.38B.
ENTERPRISE VALUE (EV)
$31.38B
ResMed Inc.
Market Cap
$32.19B
Enterprise Value (EV)
$31.38B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ResMed Inc. (RMD) | $32.19B | $31.38B |
| Alcon Inc. (ALC)vs › | $31.49B | $35.43B |
| DexCom, Inc. (DXCM)vs › | $33.01B | $33.30B |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.40B | $32.96B |
| Biogen Inc. (BIIB)vs › | $33.45B | $40.52B |
| Mettler-Toledo International Inc. (MTD)vs › | $30.70B | $32.76B |
| Centene Corp. (CNC)vs › | $30.58B | $22.54B |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.98B | $37.97B |
| Zoetis Inc. (ZTS)vs › | $29.48B | $37.24B |
| Medline Inc. (MDLN)vs › | $29.31B | $39.62B |
Market Cap
$32.19B
Total Debt
$659.37M
Cash
$1.47B
Enterprise Value
$31.38B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
